BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30707274)

  • 1. [Precursor lesions of endometrial carcinoma].
    Lax SF
    Pathologe; 2019 Feb; 40(1):13-20. PubMed ID: 30707274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
    D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
    Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
    Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
    Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?
    Naaman Y; Diment J; Perlman S; Oustinov N; Vaisbuch E; Ben-Arie A
    Gynecol Oncol; 2015 Feb; 136(2):254-7. PubMed ID: 25524459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.
    Ip PP
    Virchows Arch; 2018 Jun; 472(6):907-917. PubMed ID: 29445890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal p16 expression is significantly increased in endometrial carcinoma.
    Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
    Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
    Park CK; Yoon G; Cho YA; Kim HS
    Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5.
    Obstet Gynecol; 2023 Sep; 142(3):735-744. PubMed ID: 37590985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.
    Kendall BS; Ronnett BM; Isacson C; Cho KR; Hedrick L; Diener-West M; Kurman RJ
    Am J Surg Pathol; 1998 Aug; 22(8):1012-9. PubMed ID: 9706982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?
    Travaglino A; Raffone A; Saccone G; Mascolo M; Pignatiello S; Mollo A; De Placido G; Insabato L; Zullo F
    APMIS; 2019 Apr; 127(4):161-169. PubMed ID: 30803040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
    Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New features in the 2014 WHO classification of uterine neoplasms].
    Lax SF
    Pathologe; 2016 Nov; 37(6):500-511. PubMed ID: 27738815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Characteristics and
    Sung JY; Jung YY; Kim HS
    Anticancer Res; 2018 May; 38(5):2779-2786. PubMed ID: 29715099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
    Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
    Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.